Home
About Us
Pipeline
Partnerships
Investors
News & Events
Careers
| S*BIO Vision | Background | S*BIO Management | Board of Directors | Scientific Advisory Board | Corporate Values |
| Clinical Trials | Technologies & Capabilities |
| News & Press Releases | Participation in Events | Publications |
| Join Our Team | Career Opportunities |
 |
 |
|
The best scientist is open to experience and begins with romance - the idea that anything is possible. Ray Bradbury |
|
|
|
2006 Publications Journal of Biomolecular Screening 2006; 11(8): 959 – 967 SIRT1 modulating compounds from high-throughput screening as anti-inflammatory and insulin-sensitizing agents Vasantha M. Nayagam, Xukun Wang, Yong Cheng Tan, Anders Poulsen, Kee Chuan Goh, Tony Ng, Haishan Wang, Hong Yan Song, Binhui Ni, Michael Entzeroth and Walter Stunkel The Royal Society of Chemistry, London 2006 Concepts for in vitro profiling - Drug Activity, Selectivity and Liability. In: Exploiting Chemical Diversity for Drug Discovery Michael Entzeroth, M.B. Bolger, R. Frackiewcz and B. Steere 18th EORTC-NCI-AACR symposium: "Molecular Targets and Cancer Therapeutics" in Prague, 7-10 November 2006 ADME and PK/PD attributes of SB939, potent orally active HDAC inhibitor Kanda Sangthongpitag, Haishang Wang, Pauline Yeo, Xin Liu, Evelyn Goh, Lee Sun New, Peizi Zeng, Venkatesh. P, Xiaofeng Wu, Changyong Hu and Kantharaj Ethirajulu 18th EORTC-NCI-AACR symposium: "Molecular Targets and Cancer Therapeutics" in Prague, 7-10 November 2006 Pharmacological profile of SB939, a novel, potent and orally active histone deacetylase inhibitor Jeanette Wood, Kanda Sangthongpitag, Haishang Wang, Pauline Yeo, Xin Liu, Evelyn Goh, Lee Sun New, Peizi Zeng, Venkatesh. P, Xiaofeng Wu, Changyong Hu and Kantharaj Ethirajulu (Abstracts of Papers) 232nd ACS National Meeting in San Francisco, CA, USA, 10-14 September 2006, MEDI-575 Oral presentation: Design, synthesis, and SAR of novel benzimidazole based HDAC inhibitors Haishan Wang (Abstracts of Papers) 232nd ACS National Meeting in San Francisco, CA, USA, 10-14 September 2006, MEDI-146 Synthesis and SAR of N-hydroxy-1,2-disubstituted-1H-benzoimidazol-5-yl-acrylamides as a novel class of histone deacetylase inhibitors Haishan Wang, Niefang Yu, Hongyan Song, Dizhong Chen, Weiping Deng, Pek Ling Lye, Yong Zou, Melvin Ng, Joyce Chang, Eric T. Sun, Kanda Sangthongpitag, Xukun Wang, Xiaofeng Wu, Hwee Hoon Khng, Siok Kun Goh, Pauline Yeo, Xin Liu, Evelyn Goh, Lee Sun New, Kantharaj Ethirajulu and Michael Entzeroth 9th European ISSX Meeting in Manchester, UK, 4-7 June 2006 Comparative Pharmacokinetics of HDAC Inhibitors in the Pharmacological Species Pauline Yeo, Liu Xin, Evelyn Goh, Lee Sun New, Peizi Zeng, Xiaofeng Wu, Changyong Hu, Tony Ng, Kanda Sangthongpitag, Haishang Wang, Eric Sun and Kantharaj Ethirajulu 97th Annual AACR meeting in Washington DC, April 2006 Potent Antitumor Activity of N-Hydroxy-3-benzimidazol-5-yl acrylamides Kanda Sangthongpitag, Xukun Wang, Xiaofeng Wu, Hwee Hoon Khng, Siok Kun Goh, Changyong Hu, Pauline Yeo, Xin Liu, Niefang Yu, Haishan Wang, Kantharaj Ethirajulu, Eric T. Sun, and Michael Entzeroth
|
